| Product Name |
Etravirine
|
| Product Category |
Pharmaceutical API's, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Enzyme Inhibitors, Fine Chemicals, Non Nucleoside Reverse Transcriptase Inhibitors |
| CAS No |
269055-15-4 |
| Catalog Number |
GS.42.ETN.00 |
| Chemical Name/Synonyms |
4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-benzonitrile ; 4-((6-Amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile ; 4-[6-Amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile |
| Molecular Weight |
435.28 |
| Molecular Formula |
C20H15BrN6O |
| Purity |
NLT 98% |
| Appearance |
White to Off-White Solid |
| Solubility |
DMSO, Methanol |
| Applications |
Etraverine is used clinically for the treatment of human immunodeficiency virus type 1 infection. It is an antiretroviral agent more specifically classified as a Non-Nucleoside Reverse Transcriptase Inhibitor. |
| Inventory Status |
QC Pending
|
